| Price | 0.175p on 19-10-2026 at 05:00:12 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Sell 530,000.00 at 0.1705p |
| Day's Volume: | 0 |
| Last Close: | 0.175p |
| Open: | 0.00p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 0.165p - 0.265p |
| Market Capitalisation: | £3.76m |
| VWAP: | 0.00p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 530,000 | 0.1705p | Ordinary |
16:29:53 - 16-Oct-26 |
| Buy* | 2,878,639 | 0.1764p | Ordinary |
12:45:40 - 16-Oct-26 |
| Buy* | 2,714,363 | 0.1767p | Ordinary |
10:02:32 - 16-Oct-26 |
| Sell* | 2,940,964 | 0.171p | Ordinary |
15:06:52 - 15-Oct-26 |
| Buy* | 530,000 | 0.177p | Ordinary |
10:08:06 - 15-Oct-26 |
| Buy* | 28,249 | 0.177p | Ordinary |
08:42:36 - 15-Oct-26 |
| Buy* | 89,635 | 0.1785p | Ordinary |
16:26:27 - 13-Oct-26 |
| Unknown* | 4,050,000 | 0.1775p | Ordinary |
15:26:54 - 13-Oct-26 |
| Unknown* | 4,050,000 | 0.1705p | Ordinary |
15:25:50 - 13-Oct-26 |
| Sell* | 20,632 | 0.1708p | Ordinary |
12:03:04 - 13-Oct-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Oct 2026 10:56 am | RNS | Holding(s) in Company |
| 9th Oct 2026 7:00 am | RNS | Change of Nominated Adviser |
| 2nd Oct 2026 7:00 am | RNS-R | Australian partner to progress Ox-1 Phase 1 trial |
| 30th Sep 2026 7:00 am | RNS | Posting of Annual Report and Notice of AGM |
| 28th Sep 2026 7:00 am | RNS | Final Results for the year ended 31 March 2026 |
| 14th Sep 2026 7:00 am | RNS | Notice of Results and Investor Presentation |
| 11th Sep 2026 3:52 pm | RNS | Holding(s) in Company |
| 10th Sep 2026 12:33 pm | RNS | Holding(s) in Company |
| 7th Sep 2026 12:15 pm | RNS | Result of General Meeting |
| 20th Aug 2026 4:13 pm | RNS | Proposed Placing & Subscription to raise £1.05m |